POWERLINK SYSTEM
Report
- Report Number
- 2031527-2013-00165
- Event Type
- Injury
- Date Received
- July 12, 2013
- Date of Event
- June 17, 2013
- Report Date
- June 17, 2013
- Manufacturer
- ENDOLOGIX, INC.
- Product Code
- MIH
- PMA / PMN Number
- P040002
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE REMAINS IMPLANTED IN THE PATIENT, HENCE NO DEVICE EVALUATION WAS PERFORMED. HOWEVER, COMPUTED TOMOGRAPHY IMAGING POST INDEX PROCEDURE WERE PROVIDED FOR CLINICAL ASSESSMENT. BASED ON THE REVIEW, THE REPORT OF DISTAL ENDOLEAK TYPE I WAS CONFIRMED IN THE LEFT ILIAC ARTERY. AVAILABLE IMAGING SHOWS TORTUOUS ANATOMY AND LEFT ILIAC CALCIFICATION. THE LIKELY CAUSE OF THE ENDOLEAK APPEARS TO BE RELATED TO THE VESSEL TORTUOSITY AND CALCIFICATION. REVIEW OF THE MANUFACTURING RECORDS DID NOT INDICATE THAT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. ENDOLEAKS ARE A KNOWN RISK OF THE PROCEDURE, AND ARE IDENTIFIED IN THE PRODUCT LABELING UNDER POTENTIAL ADVERSE EVENTS.
ENDOLOGIX CONTINUES TO INVESTIGATE THE REPORTED EVENT. ENDOLOGIX WILL SUBMIT A SUPPLEMENTAL REPORT IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE. REMAINS IMPLANTED IN THE PATIENT.
IT WAS REPORTED THAT APPROXIMATELY 2 MONTHS POST-IMPLANT OF A BIFURCATED DEVICE, A SUPRARENAL AORTIC EXTENSION AND TWO LIMB EXTENSIONS, A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN REVEALED A DISTAL TYPE 1 ENDOLEAK ON THE LEFT LIMB. THE PATIENT WAS TREATED 3 MONTHS LATER WITH AN ADDITIONAL LIMB EXTENSION, WHICH SUCCESSFULLY CORRECTED THE ENDOLEAK. REPORTEDLY, THE PATIENT TOLERATED THE PROCEDURE WELL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 324121 | POWERLINK SYSTEM | INFRARENAL BIFURCATED STENT GRAFT | MIH | ENDOLOGIX, INC. | 28-16-140BL | 1062538-002 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Required Intervention |